Jorma J. De Ronde
Amsterdam, NH 1066CX, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
REV7 counteracts DNA double-strand break resection and affects PARP inhibition.
Journal: Nature
Published: February 17, 2014
Breast cancer subtype specific classifiers of response to neoadjuvant chemotherapy do not outperform classifiers trained on all subtypes.
Journal: PloS one
Published: October 28, 2013
Identifying subgroup markers in heterogeneous populations.
Journal: Nucleic acids research
Published: September 25, 2013
Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response.
Journal: Breast cancer research and treatment
Published: March 22, 2013
Platform comparisons for identification of breast cancers with a BRCA-like copy number profile.
Journal: Breast cancer research and treatment
Published: January 11, 2013
SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancer.
Journal: Breast cancer research and treatment
Published: September 20, 2012
Selection of patients for hepatic surgery of colorectal cancer liver metastasis based on genomic aberrations.
Journal: Annals of surgical oncology
Published: June 07, 2012
Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.
Journal: Breast cancer research and treatment
Published: May 04, 2012
Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response.
Journal: Breast cancer research and treatment
Published: June 02, 2009
Showing 1-11 of 11
Last Updated: 09/26/2026